Litcius/Paper detail

Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON)

Taiki Hakozaki, Kentaro Tanaka, Yoshimasa Shiraishi, Yuta Sekino, Noriko Mitome, Yusuke Okuma, Tomoiki Aiba, Takahiro Utsumi, Junko Tanizaki, Koichi Azuma, Satoshi Hara, Ryo Morita, Seiji Niho, Toshihide Yokoyama, Ryo Toyozawa, Hidehito Horinouchi, Isamu Okamoto, Yukio Hosomi, Y. Ohe

2025Journal of Thoracic Oncology13 citationsDOI

Topics & Concepts

MedicineBiomarkerImmunotherapyLung cancerOncologyInternal medicineGut floraCancerImmunologyChemistryBiochemistryGut microbiota and healthCancer Immunotherapy and BiomarkersEsophageal Cancer Research and Treatment
Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON) | Litcius